These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 12805416)
1. Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages. Song E; Lee SK; Dykxhoorn DM; Novina C; Zhang D; Crawford K; Cerny J; Sharp PA; Lieberman J; Manjunath N; Shankar P J Virol; 2003 Jul; 77(13):7174-81. PubMed ID: 12805416 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector. Lee MT; Coburn GA; McClure MO; Cullen BR J Virol; 2003 Nov; 77(22):11964-72. PubMed ID: 14581533 [TBL] [Abstract][Full Text] [Related]
3. Targeting CCR5 with siRNAs: using recombinant SV40-derived vectors to protect macrophages and microglia from R5-tropic HIV. Cordelier P; Morse B; Strayer DS Oligonucleotides; 2003; 13(5):281-94. PubMed ID: 15000819 [TBL] [Abstract][Full Text] [Related]
4. Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication. Martínez MA; Gutiérrez A; Armand-Ugón M; Blanco J; Parera M; Gómez J; Clotet B; Esté JA AIDS; 2002 Dec; 16(18):2385-90. PubMed ID: 12461411 [TBL] [Abstract][Full Text] [Related]
5. Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection. Anderson J; Akkina R Gene Ther; 2007 Sep; 14(17):1287-97. PubMed ID: 17597795 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site. Han W; Wind-Rotolo M; Kirkman RL; Morrow CD Virology; 2004 Dec; 330(1):221-32. PubMed ID: 15527848 [TBL] [Abstract][Full Text] [Related]
7. Co-receptor usage was more predictive than NSI/SI phenotype for HIV replication in macrophages: is NSI/SI phenotyping sufficient? Lathey JL; Brambilla D; Goodenow MM; Nokta M; Rasheed S; Siwak EB; Bremer JW; Huang DD; Yi Y; Reichelderfer PS; Collman RG J Leukoc Biol; 2000 Sep; 68(3):324-30. PubMed ID: 10985247 [TBL] [Abstract][Full Text] [Related]
8. Fcgamma receptor-mediated suppression of human immunodeficiency virus type 1 replication in primary human macrophages. Perez-Bercoff D; David A; Sudry H; Barré-Sinoussi F; Pancino G J Virol; 2003 Apr; 77(7):4081-94. PubMed ID: 12634367 [TBL] [Abstract][Full Text] [Related]
9. Targets of small interfering RNA restriction during human immunodeficiency virus type 1 replication. Gao Y; Lobritz MA; Roth J; Abreha M; Nelson KN; Nankya I; Moore-Dudley DM; Abraha A; Gerson SL; Arts EJ J Virol; 2008 Mar; 82(6):2938-51. PubMed ID: 18199654 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4. Zhou N; Fang J; Mukhtar M; Acheampong E; Pomerantz RJ Gene Ther; 2004 Dec; 11(23):1703-12. PubMed ID: 15306840 [TBL] [Abstract][Full Text] [Related]
11. CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection. Naif HM; Li S; Alali M; Sloane A; Wu L; Kelly M; Lynch G; Lloyd A; Cunningham AL J Virol; 1998 Jan; 72(1):830-6. PubMed ID: 9420295 [TBL] [Abstract][Full Text] [Related]
13. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Qin XF; An DS; Chen IS; Baltimore D Proc Natl Acad Sci U S A; 2003 Jan; 100(1):183-8. PubMed ID: 12518064 [TBL] [Abstract][Full Text] [Related]
14. Intestinal macrophages display reduced permissiveness to human immunodeficiency virus 1 and decreased surface CCR5. Li L; Meng G; Graham MF; Shaw GM; Smith PD Gastroenterology; 1999 May; 116(5):1043-53. PubMed ID: 10220496 [TBL] [Abstract][Full Text] [Related]
15. RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice. Kim SS; Peer D; Kumar P; Subramanya S; Wu H; Asthana D; Habiro K; Yang YG; Manjunath N; Shimaoka M; Shankar P Mol Ther; 2010 Feb; 18(2):370-6. PubMed ID: 19997090 [TBL] [Abstract][Full Text] [Related]
16. Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins. Boden D; Pusch O; Silbermann R; Lee F; Tucker L; Ramratnam B Nucleic Acids Res; 2004; 32(3):1154-8. PubMed ID: 14966264 [TBL] [Abstract][Full Text] [Related]
17. Restriction of HIV type 1 infection in macrophages heterozygous for a deletion in the CC-chemokine receptor 5 gene. Ometto L; Zanchetta M; Cabrelle A; Esposito G; Mainardi M; Chieco-Bianchi L; De Rossi A AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1441-52. PubMed ID: 10555107 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV-1 replication by siRNA targeting conserved regions of gag/pol. Morris KV; Chung CH; Witke W; Looney DJ RNA Biol; 2005 Jan; 2(1):17-20. PubMed ID: 17132935 [TBL] [Abstract][Full Text] [Related]